Canada Life’s Acorda Therapeutics ACOR Stock Holding History

Canada Life’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-379	Closed	-$42K	–	2818
2020 Q1	$42K	Hold	379	–	–	﹤0.01%	2183
2019 Q4	$92K	Buy	+379	New	+$95.6K	﹤0.01%	2088
2019 Q3	–	Sell	-418	Closed	-$383K	–	2466
2019 Q2	$383K	Hold	418	–	–	﹤0.01%	1857
2019 Q1	$667K	Hold	418	–	–	﹤0.01%	1549
2018 Q4	$721K	Hold	418	–	–	﹤0.01%	1540
2018 Q3	$983K	Sell	418 -83	-17%	-$257K	﹤0.01%	1531
2018 Q2	$1.72M	Hold	501	–	–	﹤0.01%	1278
2018 Q1	$1.42M	Hold	501	–	–	﹤0.01%	1352
2017 Q4	$1.29M	Sell	501 -23	-4%	-$65.4K	﹤0.01%	1421
2017 Q3	$1.46M	Sell	524 -45	-8%	-$119K	﹤0.01%	1349
2017 Q2	$1.34M	Buy	569 +22	+4%	+$43.6K	﹤0.01%	1396
2017 Q1	$1.37M	Buy	547 +51	+10%	+$147K	﹤0.01%	1352
2016 Q4	$1.12M	Sell	496 -18	-4%	-$42.8K	﹤0.01%	1438
2016 Q3	$1.29M	Buy	514 +21	+4%	+$62.7K	﹤0.01%	1316
2016 Q2	$1.51M	Buy	493 +454	+1,164%	+$1.48M	﹤0.01%	1196
2016 Q1	$123K	Hold	39	–	–	﹤0.01%	1646
2015 Q4	$199K	Hold	39	–	–	﹤0.01%	1286
2015 Q3	$123K	Hold	39	–	–	﹤0.01%	1554
2015 Q2	$154K	Hold	39	–	–	﹤0.01%	1536
2015 Q1	$154K	Hold	39	–	–	﹤0.01%	1495
2014 Q4	$189K	Hold	39	–	–	﹤0.01%	1333
2014 Q3	$158K	Buy	39 +24	+160%	+$90K	﹤0.01%	1347
2014 Q2	$59K	Hold	15	–	–	﹤0.01%	1873
2014 Q1	$66K	Hold	15	–	–	﹤0.01%	1631
2013 Q4	$51K	Buy	+15	New	+$58.5K	﹤0.01%	1777

Other funds holding ACOR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canada Life's ACOR Position: Q2 2020 in Review

Canada Life sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 379 shares — an estimated $42K sold.

Canada Life first reported a position in ACOR in Q4 2013 and held it in 25 quarters. The position peaked at $1.72M in Q2 2018. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

Canada Life reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
Canada Life sold 379 Acorda Therapeutics shares in Q2 2020, an estimated $42K.
Canada Life first reported a position in Acorda Therapeutics in Q4 2013 and held it in 25 quarters.
Canada Life's Acorda Therapeutics position peaked at $1.72M in Q2 2018.
79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Canada Life's 13F filing for Q2 2020, filed 17 Aug 2020.